Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men between 40 and 80 years of age
- People who have been diagnosed with low- to intermediate-risk prostate cancer, confirmed by tissue testing, with a Gleason score of 7 or less and a primary grade of 4 or less
- People whose prostate cancer is at a clinical stage of T1c or T2 (an early stage of prostate cancer)
- People whose MRI scan shows a suspicious area, or whose cancer has been mapped to one side of the prostate using a specific 3D scanning device
- People whose MRI-visible tumour measures less than 20mm in size
- People where the suspicious area seen on MRI matches the area found to be positive for cancer on biopsy
- People with a PSA (prostate-specific antigen) blood test result below 15 ng/mL
- People who have completed specific questionnaires about urinary and sexual health before the procedure
- People with a life expectancy of more than 10 years, based on other health conditions unrelated to prostate cancer
Who may not be able to join:
- People who are not considered medically suitable for a targeted prostate treatment
- People who are unwilling or unable to provide informed consent
- People who have received hormone therapy to lower androgen levels
- People who have received or are currently receiving chemotherapy for prostate cancer
- People who have previously had surgery on the prostate, including traditional, keyhole, or minimally invasive procedures such as HIFU, TUNA, RITA, microwave therapy, or cryotherapy
- People who have had radiation therapy for prostate cancer or to the pelvic area
- People with a history of not following medical advice or treatment plans
- People who are unwilling or unable to complete the self-assessment questionnaires required by the study
- People with certain prostate or bladder conditions such as chronic or acute prostatitis, neurogenic bladder, urinary tract infection, sphincter problems, or other conditions affecting normal urination
- People who have taken part in another clinical study or received an investigational treatment within the past 90 days
- People who cannot have an MRI scan, for example due to a pacemaker, hip replacement, severe claustrophobia, a brain aneurysm clip, or an allergy to MRI contrast dye
- People with any other health condition or history of illness that, in the opinion of the study investigator, could affect the study results or increase risk to the patient (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sangeet Ghai, MD, Director; Biopsy Centre, Abdominal Division and Joint Department of Medical Imaging
Phone: 416-340-4800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The proportion of study patients clinically free of clinically significant PCa (i.e. requires definitive treatment); The proportion of study patients clinically free of clinically significant PCa (i.e. requires definitive treatment)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.